title: Curiouser and Curiouser: The Macrocyclic Lactone, Abamectin, Is also a Potent Inhibitor of Pyrantel/Tribendimidine Nicotinic Acetylcholine Receptors of Gastro-Intestinal Worms.
abstract: Nematode parasites may be controlled with drugs, but their regular application has given rise to concerns about the development of resistance. Drug combinations may be more effective than single drugs and delay the onset of resistance. A combination of the nicotinic antagonist, derquantel, and the macrocyclic lactone, abamectin, has been found to have synergistic anthelmintic effects against gastro-intestinal nematode parasites. We have observed in previous contraction and electrophysiological experiments that derquantel is a potent selective antagonist of nematode parasite muscle nicotinic receptors; and that abamectin is an inhibitor of the same nicotinic receptors. To explore these inhibitory effects further, we expressed muscle nicotinic receptors of the nodular worm, Oesophagostomum dentatum (Ode-UNC-29:Ode-UNC-63:Ode-UNC-38), in Xenopus oocytes under voltage-clamp and tested effects of abamectin on pyrantel and acetylcholine responses. The receptors were antagonized by 0.03 μM abamectin in a non-competitive manner (reduced Rmax, no change in EC50). This antagonism increased when abamectin was increased to 0.1 μM. However, when we increased the concentration of abamectin further to 0.3 μM, 1 μM or 10 μM, we found that the antagonism decreased and was less than with 0.1 μM abamectin. The bi-phasic effects of abamectin suggest that abamectin acts at two allosteric sites: one high affinity negative allosteric (NAM) site causing antagonism, and another lower affinity positive allosteric (PAM) site causing a reduction in antagonism. We also tested the effects of 0.1 μM derquantel alone and in combination with 0.3 μM abamectin. We found that derquantel on these receptors, like abamectin, acted as a non-competitive antagonist, and that the combination of derquantel and abamectin produced greater inhibition. These observations confirm the antagonistic effects of abamectin on nematode nicotinic receptors in addition to GluCl effects, and illustrate more complex effects of macrocyclic lactones that may be exploited in combinations with other anthelmintics.
authors.affiliation: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Melanie
authors.initials: M
authors.lastname: Abongwa
authors.affiliation: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Samuel K
authors.initials: SK
authors.lastname: Buxton
authors.affiliation: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Alan P
authors.initials: AP
authors.lastname: Robertson
authors.affiliation: Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Martin
mesh_terms: D000109:Acetylcholine / Q000737:chemistry; D000495:Allosteric Site; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage; D003001:Cloning, Molecular; D004305:Dose-Response Relationship, Drug; D041981:Gastrointestinal Tract / Q000469:parasitology; D005786:Gene Expression Regulation; D006189:Haemonchus / Q000378:metabolism; D006373:Helminthiasis / Q000188:drug therapy; D007211:Indoles / Q000008:administration & dosage*; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D007559:Ivermectin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D009348:Nematoda / Q000187:drug effects*; D018733:Nicotinic Antagonists / Q000008:administration & dosage; D009865:Oocytes / Q000166:cytology / Q000469:parasitology; D010082:Oxepins / Q000008:administration & dosage*; D018408:Patch-Clamp Techniques; D010655:Phenylenediamines / Q000037:antagonists & inhibitors*; D011715:Pyrantel / Q000037:antagonists & inhibitors*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D014982:Xenopus laevis
chemical_list: D000871:Anthelmintics; D007211:Indoles; D018733:Nicotinic Antagonists; D010082:Oxepins; D010655:Phenylenediamines; D011978:Receptors, Nicotinic; C575297:derquantel; C056017:tribendimidine; D011715:Pyrantel; C048324:abamectin; D007559:Ivermectin; D000109:Acetylcholine